NCT00561639
- Conditions
- Disease, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- University Hospital of Grenoble Grenoble, France
Clinical trial condition
Hematologic Diseases
Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.
448 public trials
58 recruiting studies
Hematologic Diseases trial results
NCT00005154
- Conditions
- Blood Disease, Cardiovascular Diseases, Coronary Disease, +8 more
- Locations
-
Not specified
NCT00390988
- Conditions
- Healthy Volunteers, Hematologic Diseases, Hematological Diseases, +1 more
- Locations
-
Not specified
Completed
Early Application of CPAP in Hematologic
NCT00507533
- Conditions
- Hematologic Disease, Hematologic Diseases, Hemic and Lymphatic Diseases
- Locations
-
- Università degli Studi Torino Turin, Piedmont, Italy
NCT00484848
- Conditions
- Hematologic Disease, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
- Locations
-
- University Hospitals Leuven Leuven, Belgium
Completed
Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
NCT00010387
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +28 more
- Locations
-
- Johns Hopkins Oncology Center Baltimore, Maryland, United States
NCT00004485
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +11 more
- Locations
-
- Children's Hospital of Oakland Oakland, California, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00005652
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
- Locations
-
- University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States
Completed
Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns
NCT00004382
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
- Locations
-
Not specified
Completed
Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma
NCT00113204
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
- Locations
-
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Hackensack University Medical Center The David Jurist Research Center Hackensack, New Jersey, United States
- St. Vincent's Comprehensive Cancer Center New York, United States